• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL PORTICO; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL PORTICO; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number PRT-23
Device Problems Migration or Expulsion of Device (1395); Off-Label Use (1494)
Patient Problem Insufficient Information (4580)
Event Date 03/14/2022
Event Type  Death  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This event is being reported due to the migration of the 23mm portico valve.It was reported that on (b)(6) 2022, a 23mm portico valve was chosen for implant into a 21mm non-abbott surgical valve.When the non-abbott guidewire was crossing the anatomy, the patient went into cardiac arrest.Cardiac massage was provided.The starting implant depth of the portico valve at deployment was 3-4mm, and the final implant depth at release was 3mm.The tension was completely removed in the delivery system at the time of final deployment.The patient had a normal aortic angle.The portico valve popped up.There was no interaction between the delivery system and the deployed valve, and there was no post-dilatation.The migrated valve did not block a coronary artery.The user repositioned the valve with a snare.A 20mm non-abbott valve was implanted within the first via a valve-in-valve procedure.The patient was in cardiac arrest for 45 minutes, and the patient recovered a rhythm before leaving the operating room.The cardiac arrest was believed to be due to the procedure itself and the patient condition, as the cardiac arrest occurred before the installation of the valve.The cardiac arrest is not related to the portico valve as it occurred prior to the valve being implanted.
 
Manufacturer Narrative
An event of the valve migrating after implant, cardiac arrest prior to the valve entering the patient and patient death due to intra-cranial hyper-tension due to the cardio-respiratory arrest was reported.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.Please note, per the instructions for use 'once the valve is fully deployed, repositioning and retrieval of the valve is not possible.Attempted retrieval (e.G., use of a guidewire, snare, or forceps) may cause aortic root, coronary artery, and/or myocardial damage." b2 - outcomes attributed to ae updated to reflect death.H1.Updated to death due to additional information.H6.Health effect - impact code - added code 1802 death.
 
Event Description
It was reported that on 14 march 2022, a 23mm portico valve was chosen for implant into a 21mm non-abbott surgical valve.When the non-abbott guidewire was crossing the anatomy, the patient went into cardiac arrest.Cardiac massage was provided.The starting implant depth of the portico valve at deployment was 3-4mm, and the final implant depth at release was 3mm.The tension was completely removed in the delivery system at the time of final deployment.The patient had a normal aortic angle.The portico valve migrated.There was no interaction between the delivery system and the deployed valve, and there was no post-dilatation.The migrated valve did not block a coronary artery.The user repositioned the valve with a snare.A 20mm non-abbott valve was implanted within the first via a valve-in-valve procedure.The patient was in cardiac arrest for 45 minutes, and the patient recovered a rhythm before leaving the operating room.The cardiac arrest was believed to be due to the procedure itself and the patient condition, as the cardiac arrest occurred before the installation of the valve.The cardiac arrest is not related to the portico valve as it occurred prior to the valve being implanted.Subsequent to the initially filed information, it was reported that the patient passed away on (b)(6) 2022 due to intercranial hypertension, which was due to cardiopulmonary arrest.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PORTICO
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG#3007113487
177 county road b east
st. paul MN 55117 1789
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key14072367
MDR Text Key288983264
Report Number2135147-2022-00143
Device Sequence Number1
Product Code NPT
UDI-Device Identifier05415067010728
UDI-Public05415067010728
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P190023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/11/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/01/2022
Device Model NumberPRT-23
Device Catalogue NumberPRT-23
Device Lot Number8299979
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/18/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/02/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SAFARI S GUIDEWIRE (BOSTON SCIENTIFIC)
Patient Outcome(s) Required Intervention; Death;
-
-